Nemolizumab Biosimilar - Anti-IL-31RA Antibody - Low endotoxin, Azide free (A323603)

Nemolizumab Biosimilar - Anti-IL-31RA Antibody - Low endotoxin, Azide free

Recombinant humanized monoclonal antibody to IL-31RA.

ELISA, FACS, Functional Assay, In Vivo

Human, Cynomolgus Macaque

Humanized

Monoclonal

IgG2SA - Human IgG2 with S387A mutation

kappa

Unconjugated

Protein A affinity chromatography.

Reconstitution dependent.

> 95% (by SDS-PAGE and SEC-HPLC).

Lyophilized

Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!

Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.

Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.

Class I cytokine receptor, CRL, CRL 3, CRL3, Cytokine receptor like 3, Cytokine receptor-like 3, GLM R, GLM-R, GLMR, Gp130 like monocyte receptor, GP130 like receptor, Gp130-like monocyte receptor, Gp130-like receptor, GPL, HGLM R, HGLM-R, HGLMR, IL 31 receptor subunit alpha, IL 31R subunit alpha, IL 31RA, IL-31 receptor subunit alpha, IL-31R subunit alpha, IL-31R-alpha, IL31 receptor subunit alpha, IL31R subunit alpha, IL31RA, IL31R_HUMAN, Interleukin 31 receptor A, interleukin 31 receptor subunit alpha, Interleukin-31 receptor subunit alpha, MGC125346, PLCA 2, PLCA2, PRO21384, Soluble type I cytokine receptor CRL3, ZcytoR17